These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 16436963

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A multi-factor analysis of kidney regraft outcomes.
    Gjertson DW.
    Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Delayed graft function: risk factors, consequences and parameters affecting outcome-results from MOST, A Multinational Observational Study.
    Lebranchu Y, Halimi JM, Bock A, Chapman J, Dussol B, Fritsche L, Kliem V, Oppenheimer F, Pohanka E, Salvadori M, Soergel M, Tufveson G, MOST International Study Group.
    Transplant Proc; 2005; 37(1):345-7. PubMed ID: 15808638
    [Abstract] [Full Text] [Related]

  • 6. Low 1-year cyclosporine microemulsion doses are associated with better 5-year renal graft function: an insight from MOST, a multinational observational study.
    Salvadori M, Rosati A, Bertoni E, Bock A, Chapman J, Dussol B, Fritsche L, Kliem V, Lebranchu Y, Oppenheimer F, Pohanka E, Tufveson G, Soergel M.
    Transplant Proc; 2006 May; 38(4):1010-3. PubMed ID: 16757247
    [Abstract] [Full Text] [Related]

  • 7. The natural history of renal function following orthotopic heart transplant.
    Al Aly Z, Abbas S, Moore E, Diallo O, Hauptman PJ, Bastani B.
    Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562
    [Abstract] [Full Text] [Related]

  • 8. First year renal function as a predictor of kidney allograft outcome.
    Resende L, Guerra J, Santana A, Mil-Homens C, Abreu F, da Costa AG.
    Transplant Proc; 2009 Apr; 41(3):846-8. PubMed ID: 19376368
    [Abstract] [Full Text] [Related]

  • 9. Follow-up after renal transplantation with organs from donors after cardiac death.
    Chapman J, Bock A, Dussol B, Fritsche L, Kliem V, Lebranchu Y, Oppenheimer F, Pohanka E, Salvadori M, Tufveson G.
    Transpl Int; 2006 Sep; 19(9):715-9. PubMed ID: 16918531
    [Abstract] [Full Text] [Related]

  • 10. Course of glomerular filtration rate after renal transplantation and the influence of hypertension.
    Wigger M, Drückler E, Muscheites J, Stolpe HJ.
    Clin Nephrol; 2001 Dec; 56(6):S30-4. PubMed ID: 11770810
    [Abstract] [Full Text] [Related]

  • 11. Nomograms for predicting graft function and survival in living donor kidney transplantation based on the UNOS Registry.
    Tiong HY, Goldfarb DA, Kattan MW, Alster JM, Thuita L, Yu C, Wee A, Poggio ED.
    J Urol; 2009 Mar; 181(3):1248-55. PubMed ID: 19167732
    [Abstract] [Full Text] [Related]

  • 12. Chronic kidney disease in renal transplant recipients.
    Marcén R, Pascual J, Tenorio M, Ocaña EJ, Teruel JL, Villafruela JJ, Fernández M, Burgos FJ, Ortuño J.
    Transplant Proc; 2005 Nov; 37(9):3718-20. PubMed ID: 16386516
    [Abstract] [Full Text] [Related]

  • 13. Association between preoperative allograft function (effective renal plasma flow) and the change in glomerular filtration rate among living-donor kidney transplant recipients.
    Chang SS, Hung CJ, Lin YJ, Chou TC, Chung PY, Lin YS, Lee PC.
    Transplant Proc; 2012 Jan; 44(1):248-53. PubMed ID: 22310624
    [Abstract] [Full Text] [Related]

  • 14. Primary focal segmental glomerulosclerosis--long-term outcome after pediatric renal transplantation.
    Jungraithmayr TC, Bulla M, Dippell J, Greiner C, Griebel M, Leichter HE, Plank C, Tönshoff B, Weber LT, Zimmerhackl LB, German MMF Study Group.
    Pediatr Transplant; 2005 Apr; 9(2):226-31. PubMed ID: 15787798
    [Abstract] [Full Text] [Related]

  • 15. Major effects of delayed graft function and cold ischaemia time on renal allograft survival.
    Quiroga I, McShane P, Koo DD, Gray D, Friend PJ, Fuggle S, Darby C.
    Nephrol Dial Transplant; 2006 Jun; 21(6):1689-96. PubMed ID: 16490743
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes.
    Øien CM, Reisaeter AV, Leivestad T, Dekker FW, Line PD, Os I.
    Transplantation; 2007 Mar 15; 83(5):600-6. PubMed ID: 17353781
    [Abstract] [Full Text] [Related]

  • 18. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP, Pascoe MD, Alberu J, del Carmen Rial M, Oberbauer R, Brennan DC, Campistol JM, Racusen L, Polinsky MS, Goldberg-Alberts R, Li H, Scarola J, Neylan JF, Sirolimus CONVERT Trial Study Group.
    Transplantation; 2009 Jan 27; 87(2):233-42. PubMed ID: 19155978
    [Abstract] [Full Text] [Related]

  • 19. Very early serum creatinine as a surrogate marker for graft survival beyond 10 years.
    Pascual J, Marcén R, Zamora J, Fernández AM, Burgos FJ, Villafruela JJ, Ortuño J.
    J Nephrol; 2009 Jan 27; 22(1):90-8. PubMed ID: 19229823
    [Abstract] [Full Text] [Related]

  • 20. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A, Nart A, Taşli FA, Postaci H, Aykas A, Doğan M, Sahin T.
    Nephrology (Carlton); 2008 Feb 27; 13(1):80-6. PubMed ID: 18199109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.